LONDON BROKER RATINGS: AstraZeneca cut; Barclays raises Centrica

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

----------

FTSE 100

----------

Deutsche Bank Research cuts AstraZeneca to 'sell' (hold) - price target 10,500 (11,000) pence

----------

Goldman Sachs raises Entain price target to 1,100 (1,080) pence - 'buy'

----------

Deutsche Bank Research raises Entain price target to 1,158 (1,122) pence - 'buy'

----------

JPMorgan raises Entain price target to 1,150 (1,110) pence - 'neutral'

----------

Barclays raises Centrica to 'overweight' (equal weight) - price target 210 (180) pence

----------

FTSE 250

----------

Deutsche Bank Research cuts Morgan Advanced price target to 205 (235) pence - 'hold'

----------

SMALL CAP

----------

Berenberg starts Filtronic with 'buy' - price target 196 pence

----------

Berenberg cuts Sabre Insurance price target to 190 (200) pence - 'buy'

----------

RBC cuts Brooks Macdonald price target to 1,850 (1,900) pence - 'sector perform'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Brooks Macdonald

Sabre Insurance Group

Filtronic

Morgan Advanced Materials

Centrica

Entain

Astrazeneca